Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STA-2 in Patients With Chronic Stable Angina
NCT01239511Phase 2Completed
- Sponsor
- Sinphar Pharmaceutical
- Start
- Nov 2010
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of STA-2 in angina pectoris (4 arms), sponsored by Sinphar Pharmaceutical. Primary endpoint: Change in Total Exercise Time at 6 weeks. Started Nov 2010; status: completed.
02
Drugs
STA-2
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NCT01239511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01239511.